Reduced number of CFTR molecules in erythrocyte plasma membrane of cystic fibrosis patients

References

• Barrera NP, Herbert P, Henderson RM, Martin IL, Edwardson JM. Atomic force microscopy reveals the stoichiometry and subunit arrangement of 5-HT3 receptors. Proc Natl Acad Sci USA 2005; 102: 12595–12600
   PubMedGoogle Scholar
• Barriere H, Tauc M, Poujeol P. Use of knock-out mouse models for the study of renal ion channels. J Membr Biol 2004; 198: 113–124
   PubMedGoogle Scholar
• Bennekou P. K + -valinomycin and chloride conductance of the human red cell membrane. Influence of the membrane protonophore carbonylcyanide m-chlorophenylhydrazone. Biochim Biophys Acta 1984; 776: 1–9
   PubMedGoogle Scholar
• Binnig G, Quate CF, Gerber C. Atomic force microscope. Phys Rev Lett 1986; 56: 930–933
   PubMed Web of Science ®Google Scholar
• Collins CE, Quaggiotto P, Wood L, O'Loughlin EV, Henry RL, Garg ML. Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis. Lipids 1999; 34: 551–556
   PubMed Web of Science ®Google Scholar
• Dominguez C, Gartner S, Linan S, Cobos N, Moreno A. Enhanced oxidative damage in cystic fibrosis patients. Biofactors 1998; 8: 149–153
   PubMedGoogle Scholar
• Flotte TR, Schwiebert EM, Zeitlin PL, Carter BJ, Guggino WB. Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy. Hum Gene Ther 2005; 16: 921–928
   PubMedGoogle Scholar
• Hansma HG, Kasuya K, Oroudjev E. Atomic force microscopy imaging and pulling of nucleic acids. Curr Opin Struct Biol 2004; 14: 380–385
   PubMed Web of Science ®Google Scholar
• Li H, Findlay IA, Sheppard DN. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors. Kidney Int 2004; 66: 1926–1938
   PubMed Web of Science ®Google Scholar
• Liang G, Stephenson AH, Lonigro AJ, Sprague RS. Erythrocytes of humans with cystic fibrosis fail to stimulate nitric oxide synthesis in isolated rabbit lungs. Am J Physiol Heart Circ Physiol 2005; 288: H1580–H1585
   Google Scholar
• Mairbaurl H, Schulz S, Hoffman JF. Cation transport and cell volume changes in maturing rat reticulocytes. Am J Physiol Cell Physiol 2000; 279: C1621–C1630
   Google Scholar
• Mendes F, Farinha CM, Roxo-Rosa M, Fanen P, Edelman A, Dormer R, McPherson M, Davidson H, Puchelle E, De JH, Heda GD, Gentzsch M, Lukacs G, Penque D, Amaral MD. Antibodies for CFTR studies. J Cyst Fibros 2004; 3(Suppl. 2)69–72
   PubMedGoogle Scholar
• Morales MM, Carroll TP, Morita T, Schwiebert EM, Devuyst O, Wilson PD, Lopes AG, Stanton BA, Dietz HC, Cutting GR, Guggino WB. Both the wild type and a functional isoform of CFTR are expressed in kidney. Am J Physiol 1996; 270: F1038–F1048
   Google Scholar
• Pedemonte N, Lukacs GL, Du K, Caci E, Zegarra-Moran O, Galietta LJ, Verkman AS. Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest 2005; 115: 2564–2571
   PubMed Web of Science ®Google Scholar
• Penque D, Mendes F, Beck S, Farinha C, Pacheco P, Nogueira P, Lavinha J, Malho R, Amaral MD. Cystic fibrosis F508del patients have apically localized CFTR in a reduced number of airway cells. Lab Invest 2000; 80: 857–868
   PubMedGoogle Scholar
• Raftos JE, Bookchin RM, Lew VL. Distribution of chloride permeabilities in normal human red cells. J Physiol 1996; 491(Pt 3)773–777
   PubMedGoogle Scholar
• Ramalho AS, Beck S, Meyer M, Penque D, Cutting GR, Amaral MD. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol 2002; 27: 619–627
   PubMed Web of Science ®Google Scholar
• Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA [published erratum appears in Science 1989 Sep 29;245(4925):1437]. Science 1989; 245: 1066–1073
   PubMed Web of Science ®Google Scholar
• Schillers H, Danker T, Madeja M, Oberleithner H. Plasma membrane protein clusters appear in CFTR-expressing Xenopus laevis oocytes after cAMP stimulation. J Membr Biol 2001; 180: 205–212
   PubMedGoogle Scholar
• Schillers H, Shahin V, Albermann L, Schafer C, Oberleithner H. Imaging CFTR: A tail to tail dimer with a central pore. Cell Physiol Biochem 2004; 14: 1–10
   PubMed Web of Science ®Google Scholar
• Shahin V, Hafezi W, Oberleithner H, Ludwig Y, Windoffer B, Schillers H, Kuhn JE. The genome of HSV-1 translocates through the nuclear pore as a condensed rod-like structure. J Cell Sci 2006; 119: 23–30
   PubMed Web of Science ®Google Scholar
• Shahin V, Ludwig Y, Schafer C, Nikova D, Oberleithner H. Glucocorticoids remodel nuclear envelope structure and permeability. J Cell Sci 2005; 118: 2881–2889
   PubMedGoogle Scholar
• Sheppard DN, Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev 1999; 79: S23–S45
   PubMedGoogle Scholar
• Sprague RS, Ellsworth ML, Stephenson AH, Kleinhenz ME, Lonigro AJ. Deformation-induced ATP release from red blood cells requires CFTR activity. Am J Physiol 1998; 275: H1726–H1732
   Google Scholar
• Sterling KM, Jr, Shah S, Kim RJ, Johnston NI, Salikhova AY, Abraham EH. Cystic fibrosis transmembrane conductance regulator in human and mouse red blood cell membranes and its interaction with ecto-apyrase. J Cell Biochem 2004; 91: 1174–1182
   PubMedGoogle Scholar
• Stroh C, Wang H, Bash R, Ashcroft B, Nelson J, Gruber H, Lohr D, Lindsay SM, Hinterdorfer P. Single-molecule recognition imaging microscopy. Proc Natl Acad Sci USA 2004; 101: 12503–12507
   PubMed Web of Science ®Google Scholar
• Stroh M, Zimmer JP, Duda DG, Levchenko TS, Cohen KS, Brown EB, Scadden DT, Torchilin VP, Bawendi MG, Fukumura D, Jain RK. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat Med 2005; 11: 678–682
   PubMed Web of Science ®Google Scholar
• Stumpf A, Wenners-Epping K, Walte M, Lange T, Koch HG, Haeberle J, Duebbers A, Falk S, Kiesel L, Nikova D, Bruns R, Bertram H, Oberleithner H, Schillers H. 2006. Physiological concept for a blood based CFTR test. Cell Physiol Biochem 17((1–2)):29–36. E-pub 7 February.
   PubMedGoogle Scholar
• Swihart AH, Mikrut JM, Ketterson JB, Macdonald RC. Atomic force microscopy of the erythrocyte membrane skeleton. J Microsc 2001; 204: 212–225
   PubMedGoogle Scholar
• Verloo P, Kocken CH, Van der WA, Tilly BC, Hogema BM, Sinaasappel M, Thomas AW, De Jonge HR. Plasmodium falciparum-activated chloride channels are defective in erythrocytes from cystic fibrosis patients. J Biol Chem 2004; 279: 10316–10322
   PubMedGoogle Scholar
• Wang F, Zeltwanger S, Hu S, Hwang TC. Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels. J Physiol 2000; 524(Pt. 3)637–648
   PubMedGoogle Scholar
• Ward CL, Omura S, Kopito RR. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 1995; 83: 121–127
   PubMed Web of Science ®Google Scholar
• Wilson PD. Cystic fibrosis transmembrane conductance regulator in the kidney: Clues to its role?. Exp Nephrol 1999; 7: 284–289
   PubMedGoogle Scholar
• Wine JJ. Rules of conduct for the cystic fibrosis anion channel. Nat Med 2003; 9: 827–828
   PubMedGoogle Scholar